The ERK pathway mediates behavioral manifestations of mania

Nilotinib is a highly selective inhibitor of the BCR-ABL tyrosine kinase, that is responsible for the abnormal signaling which leads to the clinical manifestations of Chronic Myelogenous Leukemia (CML). ................
................